Praxis Precision Medicines
PRAX
PRAX
287 hedge funds and large institutions have $10.2B invested in Praxis Precision Medicines in 2026 Q1 according to their latest regulatory filings, with 78 funds opening new positions, 120 increasing their positions, 67 reducing their positions, and 33 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
3.7% less ownership
Funds ownership: 117.84% → 114.15% (-3.7%)
4% less funds holding in top 10
Funds holding in top 10: 24 → 23 (-1)
71% less call options, than puts
Call options by funds: $53.8M | Put options by funds: $187M
Holders
287
Holding in Top 10
23
Calls
$53.8M
Puts
$187M
Top Buyers
| 1 | +$377M | |
| 2 | +$248M | |
| 3 | +$194M | |
| 4 |
BlackRock
New York
|
+$76.2M |
| 5 |
Janus Henderson Group
London,
United Kingdom
|
+$67.7M |
Top Sellers
| 1 | -$162M | |
| 2 | -$145M | |
| 3 | -$120M | |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$48M |
| 5 |
Adage Capital Partners
Boston,
Massachusetts
|
-$46.3M |
